Status:
COMPLETED
Study on Management Thrombosis in Greek Cancer Patients
Lead Sponsor:
Hellenic Society of Medical Oncology
Conditions:
Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
Study on Management Thrombosis in Greek cancer patients
Detailed Description
The approach that Medical Oncologists encounter the prospect of a coagulation event occurrence in cancer patients.
Eligibility Criteria
Inclusion
- Inclusion Criteria
- All patients diagnosed with histologically confirmed solid tumors that are under anticoagulation therapy, during the study timeline.
- Age ≥ 18 years
- Signed informed consent
- Exclusion Criteria
- Initiation of anticoagulation therapy before the initiation of the study in 2016
- Age \<18 years
- No signed informed consent
Exclusion
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2018
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03292107
Start Date
June 1 2016
End Date
February 28 2018
Last Update
April 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hellenic Society of Medical Oncology
Athens, Greece, 11475